VERE SA
VERE reported total assets of €4.59m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Sep 2026).
By total assets for 2025, VERE ranks among the 200 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of VERE shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -4 % Total assets +19 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
VERE's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Sep 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 04 Dec 2024
- Year ended 31 Dec 2022filed on 25 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
VERE's financial analysis
- Solvency29.5%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of VERE
VERE's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0430.067.217
- VAT number
- BE0430067217
- Peppol
- Registered · 0208:0430067217 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 18 Dec 1986
- Registered office
- 3600 Genk
- Latest accounts
- 2025 · filed on 22 Sep 2026
- Activity
- Medical specialists activities (NACE 86220)
VERE (SA) has been based in Genk since 1986, active in: medical specialists activities. For 2025, it reports a net profit of 148,623 € and equity of €1.35m; its revenue is not published. Its solvency stands at 29.5%, below the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to VERE
Companies in the same business, of comparable size and area, outside its group.
- A&E Medical specialists activities Genk · balance sheet €4.56m
- Dr. Schepers Medical specialists activities Genk · balance sheet €4.98m
- Dr. Dierick Andre Medical specialists activities Oudenaarde · balance sheet €4.53m
- Pool Anesthesiologie - Reanimation Medical specialists activities Liège · balance sheet €4.36m
- Dr. M. Wirix , Ophtalmologie Medical specialists activities Hasselt · balance sheet €4.60m
- Dr. Dirk de Coster Medical specialists activities Geetbets · balance sheet €4.61m
- Docteurs Koch - Piens , Ophtalmologie Medical specialists activities Woluwe-Saint-Lambert · balance sheet €4.57m
- Constantly Aware Medical specialists activities Watermael-Boitsfort · balance sheet €4.71m
Frequently asked questions about VERE
What is the revenue of VERE?
VERE files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of VERE?
In Belgium, the VAT number is the company number prefixed with BE: BE0430067217 for VERE, if the company is VAT-registered. Its company number (CBE) is 0430.067.217.
Where is the registered office of VERE?
According to the CBE register, the registered office of VERE is in 3600 Genk.
What is the equity of VERE?
At the close of the 2025 financial year, the equity of VERE amounts to 1,354,239 €, a solvency of 29.5% of total assets.
Who manages VERE?
The register lists 3 active mandates at VERE. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is VERE within its sector?
By total assets for 2025, VERE ranks among the 200 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of VERE
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →